Institutional & Family Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3
Closed -$329 742
2023
Q4
$329 Hold
3
﹤0.01% 686
2023
Q3
$303 Buy
+3
New +$345 ﹤0.01% 685
2022
Q3
Sell
-9
Closed -$1K 716
2022
Q2
$1K Hold
9
﹤0.01% 634
2022
Q1
$1K Buy
9
+1
+13% +$140 ﹤0.01% 681
2021
Q4
$1K Hold
8
﹤0.01% 705
2021
Q3
$1K Sell
8
-6
-43% -$785 ﹤0.01% 824
2021
Q2
$2K Sell
14
-1
-7% -$137 ﹤0.01% 808
2021
Q1
$2K Sell
15
-9
-38% -$1.08K ﹤0.01% 781
2020
Q4
$3K Buy
24
+12
+100% +$1.14K ﹤0.01% 693
2020
Q3
$1K Hold
12
﹤0.01% 772
2020
Q2
$1K Sell
12
-3
-20% -$209 ﹤0.01% 758
2020
Q1
$1K Hold
15
﹤0.01% 717
2019
Q4
$2K Hold
15
﹤0.01% 720
2019
Q3
$1K Buy
+15
New +$1.41K ﹤0.01% 769

Other funds holding CNMD

Institutional & Family Asset Management's CNMD Position: Q1 2024 in Review

Institutional & Family Asset Management sold out of CONMED (CNMD) in Q1 2024, closing a stake of 3 shares — an estimated $329 sold.

Institutional & Family Asset Management first reported a position in CNMD in Q3 2019 and held it in 14 quarters. The position peaked at $3K in Q4 2020. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Institutional & Family Asset Management reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Institutional & Family Asset Management sold 3 CONMED shares in Q1 2024, an estimated $329.
  • Institutional & Family Asset Management first reported a position in CONMED in Q3 2019 and held it in 14 quarters.
  • Institutional & Family Asset Management's CONMED position peaked at $3K in Q4 2020.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Institutional & Family Asset Management's 13F filing for Q1 2024, filed 8 May 2024.